CSTL vs FOXA · rev $187.2M vs P/E 14, rev $17.13B
Castle Biosciences Inc (CSTL) versus Fox Corp Class A (FOXA) — a side-by-side from cached financials, not a winner call.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Fox Corp Class A (FOXA) is a entertainment company listed on US.
Latest reported CSTL revenue for 2026-06-30 was $187.2M. Net income was -$16.6M. CSTL currently screens at market cap $570.2M.
Latest reported FOXA revenue for 2026-06-30 was $17.13B. Net income was $1.73B. Revenue was up 5.1% from 2025-06-30 to 2026-06-30. FOXA currently screens at market cap $24.50B and trailing P/E 14.1.
CSTL currently screens at market cap $570.2M. FOXA currently screens at market cap $24.50B and trailing P/E 14.1.
Not investment advice. Open the CSTL and FOXA stock pages for the full models.
Not investment advice.